CVSA Stock Forecast & Price Target

Covista Inc. has demonstrated robust enrollment growth, with new undergraduate enrollments increasing approximately 19% in 2009, driven by favorable economic conditions, while recent data indicates an 18% and 38% rise in Chamberlain and Walden enrollments, respectively, from 2022 to 2025. The company's EBITDA margins are projected to expand as it benefits from operating leverage associated with this enrollment growth, despite anticipated slower margin expansion due to new campus launches. Furthermore, the successful acquisition of Walden in 2020 has positioned Covista for accelerated growth in applications, which could further enhance financial performance as the company scales its operations.

Covista Inc. has faced significant challenges, notably a 22-point underperformance against the S&P over the past six months, primarily due to weaker new student enrollments at Chamberlain, which management attributes to an ineffective marketing strategy. The company has seen a decline in market share from its peak of approximately 10% in 2010, influenced by regulatory scrutiny, negative publicity, and increasing competition from traditional non-profit institutions offering online programs. Furthermore, projections indicate a dip in cash conversion from 66% in FY26E to 58% in FY27E, alongside a stagnation in overall post-secondary enrollment that poses additional hurdles for growth.